生物技术企业Avidity生物科学公司(RNA)宣布已完成6亿美元股票发行的定价以推进其临床项目并扩大商业基础设施。所筹资金将用于支持其AOC平台的开发及潜在产品上市为公司的未来增长奠定基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.